Quest Diagnostics Inc (NYSE:DGX)
$ 206.84 -0.82 (-0.39%) Market Cap: 22.90 Bil Enterprise Value: 29.29 Bil PE Ratio: 22.86 PB Ratio: 3.12 GF Score: 80/100

Quest Diagnostics Inc at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript

Feb 24, 2021 / 06:30PM GMT
Release Date Price: $115.74 (-1.49%)
Ralph Giacobbe
Citigroup Inc., Research Division - Director and Co-Head of Americas Healthcare Research

Okay. I think we're good to get started here. Thanks, everybody, for joining the Citi Healthcare Services Conference. I'm Ralph Giacobbe. I cover managed care and the facilities and provider space here at Citi. We're happy to have Quest Diagnostics here today. Joining from the company is CFO, Mark Guinan; and from IR, Shawn Bevec. Again, appreciate you guys participating. This is going to be a fireside chat format, so I am going to leave the discussion. (Operator Instructions)

Questions & Answers

Ralph Giacobbe
Citigroup Inc., Research Division - Director and Co-Head of Americas Healthcare Research

But maybe, Mark, let's just start, if you don't mind, with sort of a general update on just current trends, first, specifically with COVID. I think your guidance for the first half embeds about 100,000 tests a day. The first month, I think, trended closer to 130,000. I think we've seen a little bit of a drop-off of late. First couple of weeks of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot